Seagull Biosolutions Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 17-07-2024
- Paid Up Capital ₹ 1.53 M
as on 17-07-2024
- Company Age 13 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 256.39%
(FY 2023)
- Profit 333.53%
(FY 2023)
- Ebitda 434.25%
(FY 2023)
- Net Worth 205.85%
(FY 2023)
- Total Assets 9.37%
(FY 2023)
About Seagull Biosolutions
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.53 M, as per Ministry of Corporate Affairs (MCA) records.
Vishwas Joshi, Shruti Joshi, and Shailendra Maheshwari serve as directors at the Company.
- CIN/LLPIN
U74900PN2011PTC139460
- Company No.
139460
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 May 2011
- Date of AGM
12 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Seagull Biosolutions?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishwas Joshi  | Managing Director | 06-May-2011 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shruti Joshi | Director | 06-May-2011 | Current |
| Shailendra Maheshwari | Director | 07-Oct-2011 | Current |
Financial Performance of Seagull Biosolutions.
Seagull Biosolutions Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 256.39% increase. The company also saw a substantial improvement in profitability, with a 333.53% increase in profit. The company's net worth Soared by an impressive increase of 205.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Seagull Biosolutions?
In 2023, Seagull Biosolutions had a promoter holding of 80.76% and a public holding of 19.24%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Heart And Soul Holdings India Private LimitedActive 3 years 3 monthsShailendra Maheshwari is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Seagull Biosolutions?
Unlock and access historical data on people associated with Seagull Biosolutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Seagull Biosolutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Seagull Biosolutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
